These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32656206)

  • 1. Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an
    Kim MS; Fleres B; Lovett J; Anfinson M; Samudrala SSK; Kelly LJ; Teigen LE; Cavanaugh M; Marquez M; Geurts AM; Lough JW; Mitchell ME; Fitts RH; Tomita-Mitchell A
    Front Cell Dev Biol; 2020; 8():440. PubMed ID: 32656206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of MYH6 variants in hypoplastic left heart syndrome.
    Tomita-Mitchell A; Stamm KD; Mahnke DK; Kim MS; Hidestrand PM; Liang HL; Goetsch MA; Hidestrand M; Simpson P; Pelech AN; Tweddell JS; Benson DW; Lough JW; Mitchell ME
    Physiol Genomics; 2016 Dec; 48(12):912-921. PubMed ID: 27789736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
    Jiang Y; Habibollah S; Tilgner K; Collin J; Barta T; Al-Aama JY; Tesarov L; Hussain R; Trafford AW; Kirkwood G; Sernagor E; Eleftheriou CG; Przyborski S; Stojković M; Lako M; Keavney B; Armstrong L
    Stem Cells Transl Med; 2014 Apr; 3(4):416-23. PubMed ID: 24591732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of α-Myosin Heavy Chain (
    Anfinson M; Fitts RH; Lough JW; James JM; Simpson PM; Handler SS; Mitchell ME; Tomita-Mitchell A
    J Cardiovasc Dev Dis; 2022 May; 9(5):. PubMed ID: 35621855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Association Between Hypoplastic Left Heart Syndrome and Cardiomyopathies.
    Theis JL; Hu JJ; Sundsbak RS; Evans JM; Bamlet WR; Qureshi MY; O'Leary PW; Olson TM
    Circ Genom Precis Med; 2021 Feb; 14(1):e003126. PubMed ID: 33325730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speckle-Tracking Strain Analysis for Mapping Spatiotemporal Contractility of Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocytes.
    Izadifar M; Berecz T; Li B; Tang JKKY; Foldes G; Apati A; Nagy A
    Curr Protoc; 2023 Sep; 3(9):e889. PubMed ID: 37747346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome.
    Sun Y; Su J; Wang X; Wang J; Guo F; Qiu H; Fan H; Cai D; Wang H; Lin M; Wang W; Feng Y; Fu G; Gong T; Liang P; Jiang C
    EBioMedicine; 2023 Sep; 95():104741. PubMed ID: 37544203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered contractility, Ca
    Thareja SK; Anfinson M; Cavanaugh M; Kim MS; Lamberton P; Radandt J; Brown R; Liang HL; Stamm K; Afzal MZ; Strande J; Frommelt MA; Lough JW; Fitts RH; Mitchell ME; Tomita-Mitchell A
    Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H149-H162. PubMed ID: 37204873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous NOTCH1 mutations underlie impaired cardiogenesis in a patient with hypoplastic left heart syndrome.
    Theis JL; Hrstka SC; Evans JM; O'Byrne MM; de Andrade M; O'Leary PW; Nelson TJ; Olson TM
    Hum Genet; 2015 Sep; 134(9):1003-11. PubMed ID: 26164125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of recurrent hypoplastic left heart syndrome associated with MYH6 variants: a case report.
    Najib B; Quibel T; Tessier A; Mortreux J; Bouvagnet P; Cohen C; Vialard F; Dard R
    BMC Cardiovasc Disord; 2023 Mar; 23(1):116. PubMed ID: 36890431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis.
    Hrstka SC; Li X; Nelson TJ;
    Stem Cells; 2017 Apr; 35(4):1106-1119. PubMed ID: 28142228
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Higgins EM; Bos JM; Dotzler SM; John Kim CS; Ackerman MJ
    Circ Genom Precis Med; 2019 Nov; 12(11):e002648. PubMed ID: 31638832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome.
    Theis JL; Vogler G; Missinato MA; Li X; Nielsen T; Zeng XI; Martinez-Fernandez A; Walls SM; Kervadec A; Kezos JN; Birker K; Evans JM; O'Byrne MM; Fogarty ZC; Terzic A; Grossfeld P; Ocorr K; Nelson TJ; Olson TM; Colas AR; Bodmer R
    Elife; 2020 Oct; 9():. PubMed ID: 33006316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome.
    Yagi H; Xu X; Gabriel GC; Lo C
    Adv Exp Med Biol; 2024; 1441():947-961. PubMed ID: 38884763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.
    Joshi J; Albers C; Smole N; Guo S; Smith SA
    Front Physiol; 2024; 15():1475152. PubMed ID: 39328831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cell modelling of HLHS underlines the contribution of dysfunctional NOTCH signalling to impaired cardiogenesis.
    Yang C; Xu Y; Yu M; Lee D; Alharti S; Hellen N; Ahmad Shaik N; Banaganapalli B; Sheikh Ali Mohamoud H; Elango R; Przyborski S; Tenin G; Williams S; O'Sullivan J; Al-Radi OO; Atta J; Harding SE; Keavney B; Lako M; Armstrong L
    Hum Mol Genet; 2017 Aug; 26(16):3031-3045. PubMed ID: 28521042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.